Steven Cohen Mirati Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $7.19 Million - $11.7 Million	258,563 New	258,563 $11.3 Million
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $3.95 Million - $5.87 Million	-108,100 Reduced 14.34%	645,500 $24 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $26.9 Million - $64.3 Million	651,753 Added 639.93%	753,600 $34.1 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $520,803 - $758,885	-8,753 Reduced 7.91%	101,847 $7.11 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $4.33 Million - $9.81 Million	110,600 New	110,600 $7.43 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $36.4 Million - $72.4 Million	-479,845 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $63.3 Million - $91.3 Million	479,845 New	479,845 $70.4 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $5.29 Million - $7.1 Million	-40,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $32.7 Million - $40.9 Million	-227,400 Reduced 85.04%	40,000 $6.46 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $8.25 Million - $11.5 Million	51,937 Added 24.1%	267,400 $45.8 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $34.9 Million - $51.8 Million	215,463 New	215,463 $47.3 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $21.1 Million - $31.2 Million	-186,721 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $13.4 Million - $22.5 Million	186,721 New	186,721 $21.3 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $42.2 Million - $76.8 Million	-596,169 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$77.91 - $109.6 $14.6 Million - $20.5 Million	187,234 Added 45.79%	596,169 $46.4 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $23.3 Million - $41 Million	391,735 Added 2277.53%	408,935 $42.1 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $750,780 - $1.36 Million	17,200 New	17,200 $1.26 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $496,000 - $735,165	-15,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $730,050 - $971,850	15,500 New	15,500 $730,000
Q2 2018 Aug 14, 2018	SELL	$26.05 - $52.4 $10.6 Million - $21.4 Million	-407,929 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $5.62 Million - $11.4 Million	327,030 Added 404.24%	407,929 $12.5 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $1.02 Million - $1.54 Million	80,899	80,899 $1.48 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account